Moreover, our findings indicate that Wnt2B transfers directly from tumor cells to fibroblasts through exosomes, thereby upregulate the expression of α-SMA and FAP in vitro and in vivo, which is correlated with our initial clinical data. This evidence concerns the gene WNT2B and neoplasm.